OMB Control No. 0910-0695
Expiration date: 2/28/2021
According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0910-0695 and the expiration date is 2/28/2021. The time required to complete this information collection is estimated to average 3 minutes per response, including the time for reviewing instructions and completing and reviewing the collection of information.
FDA RAPID – MESSAGE #13
Transmucosal Immediate Release Fentanyl (TIRF) Patient Prescriber Agreement Form (PPAF)
Introduction
The U.S. Food and Drug Administration, or FDA, hired Westat to help them get opinions about health information. Rare Patient Voice is helping Westat and FDA find people who may be interested in being interviewed about health information. To make sure you are a good fit for the interview, please take about 3 minutes to answer the questions below.
1. Do you currently take any prescription medicines around-the-clock to treat pain?
YES GO TO Q2
NO GO TO Q4
2. Is your pain due to any type of cancer?
YES
NO
Don’t Know
3. Which, if any, of these prescription medicines do you use around-the-clock to treat your pain? Select all that apply.
Hydrocodone
acetaminophen, also known as Vicodin,
Lortab, Lorcet, Norco,
or Zydone GO
TO Q8
Hydrocodone
extended-release, also known as Zohydro
or Hysingla GO
TO Q8
Hydromorphone extended-release also known
as Exalgo
or Dilaudid GO
TO Q8
Oxycodone
acetaminophen, also known as Percocet,
Endocet, or
Primlev GO
TO Q8
Oxycodone, also known as Oxycontin, Oxy IR, or Oxyfast GO TO Q8
Tramadol, also known as Ultram GO TO Q8
Codeine
acetaminophen, also known as Tylenol #3, Tylenol #4,
or
Vopac GO
TO Q8
Morphine,
also known as MS Contin, Morphine Sulfate ER,
Morphine
Sulfate IR, or Kadian GO
TO Q8
Methadone, also known as Dolophine GO TO Q8
Oxymorphone, also known as Opana GO TO Q8
Buprenorphine skin patch or film, also
known as Butrans
or Belbuca GO
TO Q8
Tapentadol, also known as Nucynta or Nucynta ER GO TO Q8
Fentanyl skin patch, also known as Duragesic GO TO Q8
Immediate Release Fentanyl tablets,
lozenges, films or sprays,
also known as Abstral, Actiq,
Fentora, Lazanda, Onsolis,
or Subsys INELIGIBLE
None of the above INELIGIBLE
4. Do you currently help manage medications for an adult who has cancer? Managing medications includes talking with this person’s healthcare provider about medications, picking up prescriptions from the pharmacy, or giving medications to the person.
Yes
No INELIGIBLE
5. What is the relationship of this person with cancer to you? If you help more than one person with cancer, select the person who experiences the most pain.
Child 18 years or older
Spouse
Partner
Parent
Mother-in-law or father-in-law
Grandparent
Brother or sister
Friend
Other (please specify this person’s relationship to you) INELIGIBLE IF PROFESSIONAL CAREGIVER
6. Does this person with cancer currently take any prescription medicines around-the-clock to treat pain?
YES GO TO Q7
NO INELIGIBLE
Don’t Know INELIGIBLE
7. Which, if any, of these prescription medicines does this person with cancer use around-the-clock to treat pain? Select all that apply.
Hydrocodone acetaminophen, also known as Vicodin, Lortab, Lorcet, Norco, or Zydone
Hydrocodone extended-release, also known as Zohydro or Hysingla
Hydromorphone extended-release also known as Exalgo or Dilaudid
Oxycodone acetaminophen, also known as Percocet, Endocet, or Primlev
Oxycodone, also known as Oxycontin, Oxy IR, or Oxyfast
Tramadol, also known as Ultram
Codeine acetaminophen, also known as Tylenol #3, Tylenol #4, or Vopac
Morphine, also known as MS Contin, Morphine Sulfate ER, Morphine Sulfate IR, or Kadian
Methadone, also known as Dolophine
Oxymorphone, also known as Opana
Buprenorphine skin patch or film, also known as Butrans or Belbuca
Tapentadol, also known as Nucynta or Nucynta ER
Fentanyl skin patch, also known as Duragesic
Immediate Release Fentanyl tablets, lozenges, films or sprays, also known as Abstral, Actiq, Fentora, Lazanda, Onsolis, or Subsys INELIGIBLE
None of the above INELIGIBLE
Don’t know INELIGIBLE
8. What is your gender?
Female
Male
9. What is your age?
Under 18 INELIGIBLE
18 to 29
30 to 49
50 to 64
65 or older INELIGIBLE
10. What is the highest grade or level of education you have completed?
Less than High School
High School Diploma or GED
Some College, including Associate’s Degree
Bachelor’s Degree (for example: BA, BS)
Graduate or Professional Degree INELIGIBLE
11. Do you currently work for pay?
YES
NO GO TO Q13
12. What kind of work do you do?
OPEN-ENDED TEXT BOX INELIGIBLE IF PROFESSIONAL CAREGIVER
13. Are you of Hispanic, Latino, or Spanish origin?
YES
NO
14. What is your race? Please select one or more.
White
Black or African-American
American Indian or Alaska Native
Asian
Native Hawaiian or other Pacific Islander
15. What state do you live in? [DROP DOWN LIST OF US STATES, INCLUDING “OUTSIDE OF THE US”] [“OUTSIDE OF THE US” INELIGIBLE]
Request for Contact Information
C1. Thank you for answering the questions. Based on your answers, you may be chosen for the interview. If you are chosen for the interview and you finish it, you will get $50. At the start of the interview, the interviewer will ask if it’s okay to audio record it. This helps Westat to make sure they hear everything you say correctly. If you are chosen for an interview, you will get a package in the mail. Make sure to have the package with you during the interview. Is it okay with you for Rare Patient Voice to share your contact information with Westat?
YES
NO INELIGIBLE
Thank and Terminate
Thank you for taking our survey. Unfortunately, based on your responses, you are not eligible for this study. However, we appreciate you taking the time to answer our questions today.
Contact Information
C2. In the space below, please give us the best information to contact you by phone, email, and regular mail. Please know that Westat will not share your information with anyone else. Your personal information will be deleted upon completion of the research project.
Contact Information
Name ______________________________________________________________________
Address 1 ___________________________________________________________________
Address 2 ___________________________________________________________________
City, State, ZIP _______________________________________________________________
Phone Number _______________________________________________________________
Email Address________________________________________________________________
Technology Preferences
C3. The Westat interviewer would like to be able to show you information on her computer screen during the interview. Westat will send directions for how to view the interviewer’s screen. Which app do you prefer for screen sharing? [SINGLE SELECT]
Skype
Google Hangouts
WebEx
I am not able to use any of these, please just call me
Closing
Thank you for your answers to these questions. If you are chosen for an interview, someone will contact you within the next 1-2 days.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Modified | 0000-00-00 |
File Created | 0000-00-00 |